scPharmaceuticals Inc (SCPH)
3.35
-0.11
(-3.18%)
USD |
NASDAQ |
Nov 22, 16:00
3.355
0.00 (0.00%)
After-Hours: 20:00
scPharmaceuticals Price to Book Value: 5.459 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 5.459 |
| November 21, 2024 | 5.638 |
| November 20, 2024 | 5.475 |
| November 19, 2024 | 5.736 |
| November 18, 2024 | 5.459 |
| November 15, 2024 | 5.638 |
| November 14, 2024 | 5.475 |
| November 13, 2024 | 6.371 |
| November 12, 2024 | 6.404 |
| November 11, 2024 | 6.893 |
| November 08, 2024 | 6.852 |
| November 07, 2024 | 7.039 |
| November 06, 2024 | 7.072 |
| November 05, 2024 | 6.632 |
| November 04, 2024 | 6.567 |
| November 01, 2024 | 6.632 |
| October 31, 2024 | 6.762 |
| October 30, 2024 | 7.268 |
| October 29, 2024 | 7.219 |
| October 28, 2024 | 7.121 |
| October 25, 2024 | 6.844 |
| October 24, 2024 | 6.811 |
| October 23, 2024 | 7.121 |
| October 22, 2024 | 7.186 |
| October 21, 2024 | 7.202 |
| Date | Value |
|---|---|
| October 18, 2024 | 7.382 |
| October 17, 2024 | 7.154 |
| October 16, 2024 | 7.186 |
| October 15, 2024 | 6.942 |
| October 14, 2024 | 6.844 |
| October 11, 2024 | 6.893 |
| October 10, 2024 | 6.648 |
| October 09, 2024 | 6.420 |
| October 08, 2024 | 6.477 |
| October 07, 2024 | 6.632 |
| October 04, 2024 | 6.974 |
| October 03, 2024 | 7.072 |
| October 02, 2024 | 7.105 |
| October 01, 2024 | 6.860 |
| September 30, 2024 | 7.430 |
| September 27, 2024 | 24.93 |
| September 26, 2024 | 23.91 |
| September 25, 2024 | 25.10 |
| September 24, 2024 | 25.80 |
| September 23, 2024 | 26.02 |
| September 20, 2024 | 28.02 |
| September 19, 2024 | 28.45 |
| September 18, 2024 | 29.37 |
| September 17, 2024 | 29.80 |
| September 16, 2024 | 29.80 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.320
Minimum
Dec 11 2019
29.80
Maximum
Sep 16 2024
4.575
Average
3.352
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.121 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.360 |
| Theriva Biologics Inc | 0.1446 |
| Oragenics Inc | 2.254 |
Price to Book Value Related Metrics
| PS Ratio | 4.516 |
| Price | 3.35 |
| Earnings Yield | -56.72% |
| Market Cap | 167.63M |